ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

YB-1 drives triple-negative breast cancer progression and paclitaxel resistance through Wnt/β-catenin pathway.

Yuan Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.